ストックスクリーナーアプリを入手
3.49
2.35%
0.08
プレマーケット:
3.49
Sana Biotechnology Inc (SANA) 最新ニュース
Sana CEO Steve Harr to give business update in May 12 webcast - Stock Titan
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference - The Globe and Mail
MSN Money - MSN
SANA stock rallies 24% after hours — how much is Mayo Clinic investing in the company? - MSN
Sana Biotechnology (NASDAQ:SANA) Shares Down 7.3%Time to Sell? - MarketBeat
Sana Biotechnology abstract accepted for presentation at ASGCT By Investing.com - Investing.com India
Sana Biotechnology to present preclinical CAR-T data at May meeting - Investing.com
Sana Biotechnology abstract accepted for presentation at ASGCT - Investing.com
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting - ChartMill
Sana Biotech surges as Eric Jackson calls it a 100-bagger - MSN
Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 Diabetes - Yahoo Finance
Sana Biotech rises as Mayo Clinic partners for diabetes therapy - MSN
Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - MSN
Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell - MarketBeat
Sana Biotechnology, Inc. ($SANA) President, CEO, and Director 2025 Pay Revealed - Quiver Quantitative
Sana Biotechnology, Inc. Files Form 8-K Current Report with SEC – Key Company Information and Details - Minichart
Sana Biotechnology | DEFA14A: Others - Moomoo
Sana Biotechnology reclassifies board member to balance director classes By Investing.com - Investing.com Australia
Sana Biotechnology Rebalances Board Classes With Director Shift - TipRanks
Sana Biotechnology reclassifies board member to balance director classes - Investing.com UK
Sana Biotechnology | DEF 14A: Definitive information statements - Moomoo
Sana Biotechnology (SANA) details 2026 virtual meeting, board elections and EY ratification - Stock Titan
Sana Biotechnology (SANA) Is Up 6.3% After Mayo-Backed SC451 Diabetes Cell Therapy CollaborationWhat's Changed - Sahm
Assessing Sana Biotechnology (SANA) Valuation After Mayo Clinic Partnership And Equity Investment - Yahoo Finance
Sana Biotechnology (SANA) Trading Range | Q4 2025: Earnings Fall ShortCommunity Sell Signals - Cổng thông tin điện tử Tỉnh Sơn La
Sana Biotechnology (SANA) Stock Stock Dividend (Grinds Lower) 2026-04-22Popular Trader Picks - Cổng thông tin điện tử tỉnh Lào Cai
Sana Biotechnology (SANA) Valuation Check After Mayo Clinic SC451 Collaboration And Recent Share Price Swing - Sahm
Sana Biotechnology Partners with Mayo Clinic for Diabetes Research - HarianBasis.co
Sana Biotechnology | 8-K: Current report - Moomoo
Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6 - Insider Monkey
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7%What's Next? - MarketBeat
10 Stocks Under $5 with Huge Upside Potential - Insider Monkey
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
SANA Should I Buy - Intellectia AI
Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race - Benzinga
Sana Biotechnology, Inc. (SANA) Stock Analysis: A Promising 147% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):